Roche (SIX: RO, ROG; OTCQX: RHHBY) and mySugr have signed an agreement under which Roche acquired all shares of mySugr GmbH. Counting more than one million users globally, mySugr is one of the leading mobile diabetes platforms in the market and will become an integral part of Roche's new patient-centered digital health services platform in diabetes care.

St Michael’s Hospital achieved a significant milestone in East Ireland's journey towards digitally enabled healthcare last week by going live with an electronic patient management system in its Emergency Department (ED). The system went live on 15th June, effectively making the ED paper-lite as the core clinical and administrative processes moved from being paper-based to electronic with no disruption to patient care.

Tejre Tobiassen suffered from a cardio arrest. During his rehabilitation, Tejre came up with the idea of an intelligent wearable that could help prevent cardio arrest and other life threatening incidents. A year after his cardio arrest, he founded ContinYou. The product is ready for sale in Norway.

ZCube, Research Venture of the pharmaceutical group Zambon, announced the second edition of Open Accelerator, the made-in-Italy fast track acceleration program dedicated to projects in life science fields. Open Accelerator is a 12-steps program providing training to international researchers, scientists and aspiring entrepreneurs that following a selection could receive a seed investment of up to a maximum of 100.000 EUR for each project.

"Everyone talks? We do" is this year's slogan of the WeDoDigital campaign initiated by the German Chambers of Industry and Commerce - a campaign that aims to honor digital success stories in 2017. Cologne-based, digital healthcare company m.Doc is one of the nationwide winners. The award was given to m.Doc's founder and CEO Admir Kulin at the G20 Young Entrepreneurs' Alliance Summit in Berlin yesterday.

The University of Tampere and TAYS (Tampere University Hospital) Heart Hospital use artificial intelligence (A.I.) technologies developed by VTT Technical Research Centre of Finland in the home care of heart patients. The objective is to recognize serious difficult-to-predict complications as early as possible using the latest methods.

Bayer Grants4Apps® is calling all mature teams, startups and companies that have a solution ready to go. The new Dealmaker is all about quality facetime between you and Grants4Apps' experts for one full day. If there is a match, you will be invited to Berlin to pitch your solution, discuss collaboration options and close a deal. Find out, if there is a mutual interest to start a bigger journey.